Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma
about
Ranpirnase Interferes with NF-κB Pathway and MMP9 Activity, Inhibiting Malignant Mesothelioma Cell Invasiveness and Xenograft GrowthActivating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of Onconase.Using antibodies to target cancer therapeutics.Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma.Onconase mediated NFKβ downregulation in malignant pleural mesothelioma.
P2860
Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma
@en
Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma.
@nl
type
label
Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma
@en
Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma.
@nl
prefLabel
Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma
@en
Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma.
@nl
P2093
P2860
P356
P1476
Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma
@en
P2093
Camillo Porta
Chiara Paglino
Luciano Mutti
P2860
P304
P356
10.2147/BTT.S2383
P577
2008-12-01T00:00:00Z